{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T15:08:13Z","timestamp":1649171293814},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00105-018-4314-3","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T08:48:40Z","timestamp":1542703720000},"page":"210-214","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201eSchmuckvoll konfigurierte Blasen\u201c am gesamten Integument bei erstdiagnostizierter Colitis ulcerosa"],"prefix":"10.1007","volume":"70","author":[{"given":"Wolfgang","family":"Konschake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Daeschlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"J\u00fcnger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stine","family":"Lutze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"4314_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1750-1172-7-49","volume":"7","author":"N Beek Van","year":"2012","unstructured":"Van Beek N, Rentzsch K, Probst C et al (2012) Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy. Orphanet J Rare Dis 7:49. \n                    https:\/\/doi.org\/10.1186\/1750-1172-7-49","journal-title":"Orphanet J Rare Dis"},{"key":"4314_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/b137790","volume-title":"Dermatologie und Venerologie","author":"O Braun-Falco","year":"2005","unstructured":"Braun-Falco O (2005) Dermatologie und Venerologie. Springer, Heidelberg"},{"key":"4314_CR3","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1001\/archderm.1995.01690240096016","volume":"131","author":"LS Chan","year":"1995","unstructured":"Chan LS, Traczyk T, Taylor TB et al (1995) Linear IgA bullous dermatosis. Characterization of a\u00a0subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies. Arch Dermatol 131:1432\u20131437","journal-title":"Arch Dermatol"},{"key":"4314_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-6-31","volume":"6","author":"K Csorba","year":"2011","unstructured":"Csorba K, Schmidt S, Florea F et\u00a0al (2011) Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases. Orphanet J Rare Dis 6:31. \n                    https:\/\/doi.org\/10.1186\/1750-1172-6-31","journal-title":"Orphanet J Rare Dis"},{"key":"4314_CR5","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0738-081X(00)00185-1","volume":"19","author":"SV Guide","year":"2001","unstructured":"Guide SV, Marinkovich MP (2001) Linear IgA bullous dermatosis. Clin Dermatol 19:719\u2013727","journal-title":"Clin Dermatol"},{"key":"4314_CR6","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00105-007-1432-8","volume":"58","author":"C G\u00fcnther","year":"2007","unstructured":"G\u00fcnther C, Hertl M, Meurer M (2007) Diagnostic use of autoantibodies. Hautarzt 58:1063\u20131074. \n                    https:\/\/doi.org\/10.1007\/s00105-007-1432-8\n                    \n                   (quiz 1075)","journal-title":"Hautarzt"},{"key":"4314_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00105-018-4192-8","volume":"69","author":"ON Horv\u00e1th","year":"2018","unstructured":"Horv\u00e1th ON, von Braunm\u00fchl T, S\u00e1rdy M (2018) Pediatric linear IgA\/IgG dermatosis. Hautarzt 69:28\u201330. \n                    https:\/\/doi.org\/10.1007\/s00105-018-4192-8","journal-title":"Hautarzt"},{"key":"4314_CR8","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/j.1365-2133.2008.08492.x","volume":"158","author":"N Ishii","year":"2008","unstructured":"Ishii N, Ohyama B, Yamaguchi Z, Hashimoto T (2008) IgA autoantibodies against the NC16a domain of BP180 but not 120-kDa LAD-1 detected in a\u00a0patient with linear IgA disease. Br J Dermatol 158:1151\u20131153. \n                    https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08492.x","journal-title":"Br J Dermatol"},{"key":"4314_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0190-9622(94)70015-X","volume":"30","author":"MK Kuechle","year":"1994","unstructured":"Kuechle MK, Stegemeir E, Maynard B et al (1994) Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature. J\u00a0Am Acad Dermatol 30:187\u2013192","journal-title":"J Am Acad Dermatol"},{"key":"4314_CR10","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.1365-2133.1997.tb03671.x","volume":"136","author":"DG Paige","year":"1997","unstructured":"Paige DG, Leonard JN, Wojnarowska F, Fry L (1997) Linear IgA disease and ulcerative colitis. Br J Dermatol 136:779\u2013782","journal-title":"Br J Dermatol"},{"key":"4314_CR11","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0190-9622(99)70253-7","volume":"41","author":"C Rose","year":"1999","unstructured":"Rose C, Dieterich W, Br\u00f6cker EB et\u00a0al (1999) Circulating autoantibodies to tissue transglutaminase differentiate patients with dermatitis herpetiformis from those with linear IgA disease. J\u00a0Am Acad Dermatol 41:957\u2013961","journal-title":"J Am Acad Dermatol"},{"key":"4314_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/gut.25.1.32","volume":"25","author":"WS Selby","year":"1984","unstructured":"Selby WS, Janossy G, Bofill M, Jewell DP (1984) Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques. Gut 25:32\u201340","journal-title":"Gut"},{"key":"4314_CR13","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1600-0625.2007.00592.x","volume":"16","author":"C Sitaru","year":"2007","unstructured":"Sitaru C, D\u00e4hnrich C, Probst C et al (2007) Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies. Exp Dermatol 16:770\u2013777. \n                    https:\/\/doi.org\/10.1111\/j.1600-0625.2007.00592.x","journal-title":"Exp Dermatol"},{"key":"4314_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/1523-1747.ep12471811","volume":"100","author":"V Thuong-Nguyen","year":"1993","unstructured":"Thuong-Nguyen V, Kadunce DP, Hendrix JD et al (1993) Inhibition of neutrophil adherence to antibody by dapsone: a\u00a0possible therapeutic mechanism of dapsone in the treatment of IgA dermatoses. J\u00a0Invest Dermatol 100:349\u2013355","journal-title":"J Invest Dermatol"},{"key":"4314_CR15","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1067\/mjd.2002.125079","volume":"47","author":"RM Vodegel","year":"2002","unstructured":"Vodegel RM, de Jong MCJM, Pas HH, Jonkman MF (2002) IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature. J\u00a0Am Acad Dermatol 47:919\u2013925. \n                    https:\/\/doi.org\/10.1067\/mjd.2002.125079","journal-title":"J Am Acad Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4314-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-018-4314-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4314-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:41:38Z","timestamp":1574210498000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-018-4314-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["4314"],"URL":"https:\/\/doi.org\/10.1007\/s00105-018-4314-3","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]},"assertion":[{"value":"20 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"W.\u00a0Konschake, G.\u00a0Daeschlein, M.\u00a0J\u00fcnger und S.\u00a0Lutze geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}